US$ 27.75
semaglutide taper schedule How long do you stay on for weight loss Semaglutide Maintenance: Taper Off Without
Description
Triagonists (for example GLP-1/GIP/glucagon) are currently in pre-clinical or early clinical development

Semaglutide (Wegovy 2.4 mg) The STEP trials, which evaluated semaglutide for weight loss, found that patients taking 2.4 mg of semaglutide weeklyachieved an average weight loss of 14.9% of their body weight over 68 weeks

Blog medically reviewed by : Palvinder Deol, GPhC Registered Pharmacist, 18 November 2025 References National Institute for Health and Care Excellence

are overweight or have obesity

An observational study in Neurology found that GLP1 diabetes drugs were associated with a lower risk of developing epilepsy compared with DPP4 inhibitors

What you need to know about Wegovy tablets for weight loss.
